$CRSP stock has now risen 13% today, according to our price data from Polygon. There has been approximately $196,692,483 of trading volume.
Here is what we see in our data on $CRSP (you can track the company live on Quiver's $CRSP stock page):$CRSP Insider Trading Activity
$CRSP insiders have traded $CRSP stock on the open market 22 times in the past 6 months. Of those trades, 4 have been purchases and 18 have been sales.
Here’s a breakdown of recent trading of $CRSP stock by insiders over the last 6 months:
- SIMEON GEORGE has made 3 purchases buying 989,812 shares for an estimated $51,499,918 and 0 sales.
- SAMARTH KULKARNI (Chief Executive Officer) has made 0 purchases and 6 sales selling 61,394 shares for an estimated $3,050,070.
- JAMES R. KASINGER (General Counsel and Secretary) has made 0 purchases and 5 sales selling 18,693 shares for an estimated $920,052.
- JOHN GREENE purchased 7,000 shares for an estimated $313,947
- RAJU PRASAD (Chief Financial Officer) has made 0 purchases and 2 sales selling 5,959 shares for an estimated $247,833.
- JULIANNE BRUNO (Chief Operating Officer) has made 0 purchases and 4 sales selling 3,435 shares for an estimated $147,300.
- NAIMISH PATEL (Chief Medical Officer) sold 3,932 shares for an estimated $141,316
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CRSP Hedge Fund Activity
We have seen 159 institutional investors add shares of $CRSP stock to their portfolio, and 168 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL INTERNATIONAL INVESTORS removed 2,670,405 shares (-30.5%) from their portfolio in Q1 2025, for an estimated $90,873,882
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,262,560 shares (+182.9%) to their portfolio in Q1 2025, for an estimated $42,964,916
- ARK INVESTMENT MANAGEMENT LLC added 1,192,336 shares (+13.3%) to their portfolio in Q1 2025, for an estimated $40,575,194
- TWO SIGMA INVESTMENTS, LP added 882,887 shares (+288.3%) to their portfolio in Q1 2025, for an estimated $30,044,644
- BALYASNY ASSET MANAGEMENT L.P. removed 810,468 shares (-90.7%) from their portfolio in Q1 2025, for an estimated $27,580,226
- MORGAN STANLEY added 804,980 shares (+162.6%) to their portfolio in Q1 2025, for an estimated $27,393,469
- TWO SIGMA ADVISERS, LP added 712,400 shares (+840.1%) to their portfolio in Q1 2025, for an estimated $24,242,972
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CRSP Analyst Ratings
Wall Street analysts have issued reports on $CRSP in the last several months. We have seen 8 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 06/27/2025
- JMP Securities issued a "Market Outperform" rating on 06/27/2025
- HC Wainwright & Co. issued a "Buy" rating on 06/27/2025
- Needham issued a "Buy" rating on 06/26/2025
- Chardan Capital issued a "Buy" rating on 06/26/2025
- Citigroup issued a "Buy" rating on 02/18/2025
- Morgan Stanley issued a "Underweight" rating on 02/14/2025
To track analyst ratings and price targets for $CRSP, check out Quiver Quantitative's $CRSP forecast page.
$CRSP Price Targets
Multiple analysts have issued price targets for $CRSP recently. We have seen 14 analysts offer price targets for $CRSP in the last 6 months, with a median target of $73.0.
Here are some recent targets:
- Gil Blum from Needham set a target price of $81.0 on 07/08/2025
- Bill Maughan from Clear Street set a target price of $45.0 on 06/27/2025
- Silvan Tuerkcan from JMP Securities set a target price of $86.0 on 06/27/2025
- Mitchell Kapoor from HC Wainwright & Co. set a target price of $65.0 on 06/27/2025
- Edward Tenthoff from Piper Sandler set a target price of $105.0 on 06/27/2025
- Geulah Livshits from Chardan Capital set a target price of $82.0 on 06/26/2025
- Gena Wang from Barclays set a target price of $42.0 on 05/09/2025
You can track data on $CRSP on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
